Cell line | Drug | Duration | Sub G1 phase % | G0/G1 phase % | S phase % | G2/M % |
HepG2 | No drug control | 48 hr | 0% | 75.54% | 24.35% | 0.11% |
HepG2 | BSO | 48 hr | 0% | 74.19% | 25.48% | 0.34% |
HepG2 | Paracetamol | 48 hr | 0% | 92.31% | 7.69% | 0% |
HepG2 | BSO + Para | 48 hr | 0% | 99.80% | 0.13% | 0.07% |
HepG2 | No drug control | 72 hr | 6.15% | 70.77% | 23.08% | 0% |
HepG2 | BSO | 72 hr | 8.02% | 69.14% | 22.84% | 0% |
HepG2 | Paracetamol | 72 hr | 37.20% | 53.62% | 6.28% | 2.90% |
HepG2 | BSO + Para | 72 hr | 24.20% | 30.57% | 29.30% | 15.92% |
HepG2 | No drug control | 96 hr | 23.27% | 59.12% | 15.72% | 1.89% |
HepG2 | BSO | 96 hr | 6.31% | 56.76% | 36.94% | 0% |
HepG2 | Paracetamol | 96 hr | 79.42% | 18.65% | 1.93% | 0% |
HepG2 | BSO + Para | 96 hr | 54.88% | 8.13% | 36.99% | 0% |
Normal Hepatocytes | No drug control | 48 hr | 27.34% | 67.63% | 4.32% | 0.72% |
Normal Hepatocytes | BSO | 48 hr | 29.17% | 62.50% | 8.33% | 0% |
Normal Hepatocytes | Paracetamol | 48 hr | 40.06% | 53.78% | 6.16% | 0% |
Normal Hepatocytes | BSO + Para | 48 hr | 22.05% | 71.79% | 5.13% | 1.03% |